-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GaHQ+w2XTobH78lEOFb8uB0SpLrhSR60SmDHdObgr57w53j4ls9XtNS5gKGOxExf Jj64GIHdZja8u570gUY3bg== 0001035704-97-000181.txt : 19970918 0001035704-97-000181.hdr.sgml : 19970918 ACCESSION NUMBER: 0001035704-97-000181 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19970901 ITEM INFORMATION: FILED AS OF DATE: 19970912 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: HESKA CORP CENTRAL INDEX KEY: 0001038133 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 770192527 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 000-22427 FILM NUMBER: 97679406 BUSINESS ADDRESS: STREET 1: 1825 SHARP POINT DR CITY: FORT COLLINS STATE: CO ZIP: 80525 BUSINESS PHONE: 9704937272 MAIL ADDRESS: STREET 1: 1825 SHARP POINT DR CITY: FORT COLLINS STATE: CO ZIP: 80525 8-K 1 FORM 8-K 9/1/97 1 FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: September 1, 1997 HESKA CORPORATION ------------------------------------------------------ (Exact name of registrant as specified in its charter) DELAWARE 000-22427 77-0192527 - ---------------- ------------ -------------- (State or other (Commission (IRS Employer jurisdiction of File Number) Identification corporation) No.) 1825 SHARP POINT DRIVE, FORT COLLINS CO 80525 - --------------------------------------- ---------- (Address of principal executive office) (Zip Code) Registrant's telephone number, including area code: (970) 493-7272 2 Item 9. Sales of Equity Securities Pursuant to Regulation S. On September 1, 1997, in connection with the acquisition of all of the outstanding shares of capital stock of CMG Centre Medical des Grands'Places SA ("CMG"), a corporation organized under the laws of Switzerland, by the registrant, the registrant issued an aggregate of 59,905 shares of its Common Stock to two shareholders of CMG in satisfaction of approximately $540,000 of the acquisition price. The issued shares were sold outside the United States to non-U.S. persons (as defined in Regulation S) in reliance on multiple exemptions from registration, including without limitation Regulation S under the Securities Act of 1933, as amended. 3 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: September 12, 1997 HESKA CORPORATION By /s/ WILLIAM G. SKOLOUT ------------------------------- WILLIAM G. SKOLOUT Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----